Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PRSS3 |
| Upstream (Parents) |
|---|
| (<<) RAB25 → PRSS3 |
| (<<) BSPRY → PRSS3 |
| (<<) PIP5K1B → PRSS3 |
| Downstream (Children) |
|---|
| PRSS3 → ARL14 (>>) |
| PRSS3 → CAPN10 (>>) |
| PRSS3 → SULT1C2 (>>) |
| PRSS3 → PRSS2 (>>) |
| PRSS3 → KRT8 (>>) |
| PRSS3 → SULT2B1 (>>) |
| PRSS3 → ELF3 (>>) |
| PRSS3 → DPH2 (>>) |
| PRSS3 → TRIM15 (>>) |
| PRSS3 → TRY6///PRSS1 (>>) |
| PRSS3 → BSPRY (>>) |
| PRSS3 → GDF15 (>>) |
| PRSS3 → CLDN7 (>>) |
| PRSS3 → CORO2A (>>) |
| PRSS3 → BACE1 (>>) |
| PRSS3 → FUT2 (>>) |
| PRSS3 → ARHGEF16 (>>) |
| PRSS3 → ABHD11 (>>) |
